{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:11:44Z","timestamp":1790367104490,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier","isbn-type":[{"value":"9780444641946","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.pbr.2018.09.014","type":"book-chapter","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T23:25:12Z","timestamp":1540509912000},"page":"37-62","source":"Crossref","is-referenced-by-count":21,"title":["Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms"],"prefix":"10.1016","author":[{"given":"Andrei I.","family":"Molosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anantha","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/bs.pbr.2018.09.014_bb0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis. Conference statement","volume":"45","author":"No Author","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jmedgenet-2013-101951","article-title":"Autism traits in the RASopathies","volume":"51","author":"Adviento","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0025","doi-asserted-by":"crossref","first-page":"57171","DOI":"10.18632\/oncotarget.11036","article-title":"Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors","volume":"7","author":"Ahsan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0030","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajmg.a.36374","article-title":"Behavioral profile in RASopathies","volume":"164A","author":"Alfieri","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/1675","article-title":"PAK3 mutation in nonsyndromic X-linked mental retardation","volume":"20","author":"Allen","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0040","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1093\/hmg\/ddu389","article-title":"Neuronal NF1\/RAS regulation of cyclic AMP requires atypical PKC activation","volume":"23","author":"Anastasaki","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/MCB.13.1.487","article-title":"A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity","volume":"13","author":"Andersen","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0050","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.3107130","article-title":"Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17","volume":"236","author":"Barker","year":"1987","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of Ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0060","doi-asserted-by":"crossref","first-page":"36609","DOI":"10.1074\/jbc.M502306200","article-title":"Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors","volume":"280","author":"Beeser","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08977190500130480","article-title":"GAPs in growth factor signalling","volume":"23","author":"Bernards","year":"2005","journal-title":"Growth Factors"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s11689-016-9181-6","article-title":"Arbaclofen in fragile X syndrome: results of phase 3 trials","volume":"9","author":"Berry-Kravis","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0075","doi-asserted-by":"crossref","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","article-title":"Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial","volume":"4","author":"Berry-Kravis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.biochem.72.121801.161742","article-title":"Biology of the p21-activated kinases","volume":"72","author":"Bokoch","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/09647041003642885","article-title":"A history of von Recklinghausen's NF1","volume":"19","author":"Brosius","year":"2010","journal-title":"J. Hist. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0095","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddq382","article-title":"Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice","volume":"19","author":"Brown","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fpsyt.2017.00069","article-title":"Autism spectrum disorders and schizophrenia spectrum disorders: excitation\/inhibition imbalance and developmental trajectories","volume":"8","author":"Canitano","year":"2017","journal-title":"Front. Psychiatry."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dmcn.12361","article-title":"Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1","volume":"56","author":"Champion","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Chang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0960-9822(00)00475-9","article-title":"Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338","volume":"10","author":"Chaudhary","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0120","doi-asserted-by":"crossref","first-page":"10977","DOI":"10.1523\/JNEUROSCI.1077-10.2010","article-title":"Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome","volume":"30","author":"Chen","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0125","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.18632\/oncotarget.2810","article-title":"Group I Paks as therapeutic targets in NF2-deficient meningioma","volume":"6","author":"Chow","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1101\/gad.1054703","article-title":"Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor","volume":"17","author":"Cichowski","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0135","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/sj.onc.1205302","article-title":"PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway","volume":"21","author":"Coles","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2307\/1127215","article-title":"Symptom patterns in hyperkinetic, neurotic, and normal children","volume":"41","author":"Conners","year":"1970","journal-title":"Child Dev."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0145","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/86898","article-title":"Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1","volume":"27","author":"Costa","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcomdis.2011.11.002","article-title":"Articulation in schoolchildren and adults with neurofibromatosis type 1","volume":"45","author":"Cosyns","year":"2012","journal-title":"J. Commun. Disord."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0160","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10519-005-9040-9","article-title":"Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children","volume":"36","author":"Coude","year":"2006","journal-title":"Behav. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0165","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0170","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.1523\/JNEUROSCI.23-26-08949.2003","article-title":"The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes","volume":"23","author":"Dasgupta","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0175","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0896-6273(92)90270-N","article-title":"The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes","volume":"8","author":"Daston","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","article-title":"Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis","volume":"69","author":"Declue","year":"1992","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0190","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1073\/pnas.1600914113","article-title":"Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity","volume":"113","author":"Deraredj Nadim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.23793","article-title":"Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice","volume":"73","author":"Diggs-Andrews","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0200","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1073\/pnas.1219383110","article-title":"Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486","volume":"110","author":"Dolan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0205","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0210","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes","volume":"53","author":"Easton","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0215","first-page":"565","article-title":"Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings","volume":"51","author":"Erdogan-Bakar","year":"2009","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0225","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0235","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1093\/emboj\/16.21.6426","article-title":"Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins","volume":"16","author":"Frost","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0240","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/MCB.16.7.3707","article-title":"Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members","volume":"16","author":"Frost","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0245","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/dmcn.13394","article-title":"Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras\/MAPK pathway","volume":"59","author":"Garg","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/bs.pbr.2018.09.014_bb0250","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis type 1 and autism spectrum disorder","volume":"132","author":"Garg","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0255","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10803-014-2321-5","article-title":"Autism spectrum disorder profile in neurofibromatosis type I","volume":"45","author":"Garg","year":"2015","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0092-8674(91)90352-Y","article-title":"Ras C-terminal processing enzymes\u2014new drug targets?","volume":"65","author":"Gibbs","year":"1991","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0265","first-page":"2151","article-title":"Catalytic properties, tissue and intracellular distribution of neurofibromin","volume":"7","author":"Golubic","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13229-017-0166-4","article-title":"Testing the excitation\/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes","volume":"8","author":"Goncalves","year":"2017","journal-title":"Mol. Autism"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0275","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.276.5313.795","article-title":"Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides","volume":"276","author":"Guo","year":"1997","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0280","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/35002593","article-title":"A neurofibromatosis-1-regulated pathway is required for learning in Drosophila","volume":"403","author":"Guo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0285","first-page":"315","article-title":"Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues","volume":"6","author":"Gutmann","year":"1995","journal-title":"Cell Growth Differ."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0290","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/hmg\/ddl023","article-title":"Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras","volume":"15","author":"Hannan","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0295","first-page":"243","article-title":"Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines","volume":"3","author":"Hashimoto","year":"2009","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0300","first-page":"1","article-title":"The direct PAK1 inhibitor, TAT-PAK18, blocks preferentially the growth of human ovarian cancer cell lines in which PAK1 is abnormally activated by autophosphorylation at Thr 423","volume":"4","author":"Hashimoto","year":"2010","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0305","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.0705003104","article-title":"Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice","volume":"104","author":"Hayashi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0092-8674(95)90403-4","article-title":"Transcriptional regulation by extracellular signals: mechanisms and specificity","volume":"80","author":"Hill","year":"1995","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0315","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41598-018-19844-7","article-title":"Abnormal behaviours relevant to neurodevelopmental disorders in Kirrel3-knockout mice","volume":"8","author":"Hisaoka","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0320","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1523\/JNEUROSCI.0933-07.2007","article-title":"Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation","volume":"27","author":"Ho","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0325","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1469-8749.2010.03639.x","article-title":"Social information processing in children and adolescents with neurofibromatosis type 1","volume":"52","author":"Huijbregts","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0330","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10519-010-9430-5","article-title":"Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1?","volume":"41","author":"Huijbregts","year":"2011","journal-title":"Behav. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0335","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1017\/S0012162206002131","article-title":"Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder","volume":"48","author":"Hyman","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0340","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0345","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0896-6273(00)80602-9","article-title":"Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation","volume":"21","author":"Impey","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0350","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0355","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/aur.1664","article-title":"Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function","volume":"10","author":"Jaramillo","year":"2017","journal-title":"Autism Res."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0360","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0365","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5582\/irdr.2014.01024","article-title":"Modeling fragile X syndrome in the Fmr1 knockout mouse","volume":"3","author":"Kazdoba","year":"2014","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0370","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-230X(08)60700-9","article-title":"Increasing complexity of Ras signal transduction: involvement of Rho family proteins","volume":"72","author":"Khosravi-Far","year":"1998","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0375","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/24184","article-title":"The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338","volume":"396","author":"King","year":"1998","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0380","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jphysparis.2014.08.007","article-title":"Participation of group I p21-activated kinases in neuroplasticity","volume":"108","author":"Koth","year":"2014","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0385","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0390","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2016.12.014","article-title":"Structure, biochemistry, and biology of PAK kinases","volume":"605","author":"Kumar","year":"2017","journal-title":"Gene"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0395","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/59.9.759","article-title":"Loss of neurofibromin is associated with activation of RAS\/MAPK and PI3-K\/AKT signaling in a neurofibromatosis 1 astrocytoma","volume":"59","author":"Lau","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0400","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1038\/sj.onc.1210261","article-title":"Tumor microenvironment and neurofibromatosis type I: connecting the GAPs","volume":"26","author":"Le","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0405","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/369411a0","article-title":"Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane","volume":"369","author":"Leevers","year":"1994","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0410","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1471-4159.2009.05975.x","article-title":"Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C\/Ras\/extracellular signal-regulated kinase 1\/2 pathway signaling and neuronal differentiation","volume":"109","author":"Leondaritis","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0415","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0420","doi-asserted-by":"crossref","first-page":"29105","DOI":"10.1074\/jbc.M113.510933","article-title":"FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas","volume":"288","author":"Licciulli","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0425","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13023-014-0142-4","article-title":"The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial","volume":"9","author":"Lion-Francois","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0430","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2141.2010.08525.x","article-title":"Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia","volume":"152","author":"Loh","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0435","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/brain.2014.0334","article-title":"Functional connectivity changes and executive and social problems in neurofibromatosis type I","volume":"5","author":"Loitfelder","year":"2015","journal-title":"Brain Connect."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0440","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2377-13-131","article-title":"Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1","volume":"13","author":"Mainberger","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0445","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/aur.1853","article-title":"Characterization of early communicative behavior in mouse models of neurofibromatosis type 1","volume":"11","author":"Maloney","year":"2018","journal-title":"Autism Res."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0450","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.onc.1209113","article-title":"Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells","volume":"25","author":"Mangoura","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0455","doi-asserted-by":"crossref","first-page":"25070","DOI":"10.1074\/jbc.270.42.25070","article-title":"Molecular cloning of a new member of the p21-Cdc42\/Rac-activated kinase (PAK) family","volume":"270","author":"Manser","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0460","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/367040a0","article-title":"A brain serine\/threonine protein kinase activated by Cdc42 and Rac1","volume":"367","author":"Manser","year":"1994","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0465","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0470","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","article-title":"The ERK1\/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition","volume":"26","author":"Meloche","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0475","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nn.3822","article-title":"Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase","volume":"17","author":"Molosh","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0480","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1212\/WNL.0000000000005000","article-title":"A genotype-phenotype correlation for quantitative autistic trait burden in neurofibromatosis 1","volume":"90","author":"Morris","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0485","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2013.10.052","article-title":"Repetitive behavior profile and supersensitivity to amphetamine in the C58\/J mouse model of autism","volume":"259","author":"Moy","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0490","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acsmedchemlett.5b00398","article-title":"Design of selective PAK1 inhibitor G-5555: improving properties by employing an unorthodox low-pK a polar moiety","volume":"6","author":"Ndubaku","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0495","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1523\/JNEUROSCI.21-14-05139.2001","article-title":"Abnormal development of dendritic spines in FMR1 knock-out mice","volume":"21","author":"Nimchinsky","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0500","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00018-007-7133-8","article-title":"Ras proteins: paradigms for compartmentalised and isoform-specific signalling","volume":"64","author":"Omerovic","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0505","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/mp.2015.48","article-title":"HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1","volume":"20","author":"Omrani","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0510","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ncb1493","article-title":"Input from Ras is required for maximal PI(3)K signalling in Drosophila","volume":"8","author":"Orme","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0515","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fnhum.2014.00386","article-title":"Neurocognitive profiles of learning disabled children with neurofibromatosis type 1","volume":"8","author":"Orraca-Castillo","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0520","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/gbb.12305","article-title":"Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI\/DTI study on social cognition","volume":"15","author":"Petrella","year":"2016","journal-title":"Genes Brain Behav."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0525","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09146","article-title":"Functional impact of global rare copy number variation in autism spectrum disorders","volume":"466","author":"Pinto","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0530","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0065-230X(08)60314-0","article-title":"Pathways of Ras function: connections to the actin cytoskeleton","volume":"62","author":"Prendergast","year":"1993","journal-title":"Adv. Cancer Res."},{"issue":"504","key":"10.1016\/bs.pbr.2018.09.014_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.aan0852","article-title":"Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome","volume":"10","author":"Pyronneau","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2018.01.006","article-title":"P21 activated kinase signaling in cancer","author":"Rane","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0545","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","volume":"151","author":"Rasmussen","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0550","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.a.33183","article-title":"Proceedings from the 2009 genetic syndromes of the Ras\/MAPK pathway: from bedside to bench and back","volume":"152A","author":"Rauen","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0555","series-title":"Neurological Eponyms","article-title":"Von Recklinghausen's disease","author":"Riccardi","year":"2000"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0560","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/370527a0","article-title":"Phosphatidylinositol-3-Oh kinase as a direct target of Ras","volume":"370","author":"Rodriguez-Viciana","year":"1994","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0565","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/j.1460-2075.1996.tb00602.x","article-title":"Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation","volume":"15","author":"Rodriguez-Viciana","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0570","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1021\/acs.jmedchem.6b00638","article-title":"Chemically diverse group I p21-activated kinase (PAK) inhibitors impart acute cardiovascular toxicity with a narrow therapeutic window","volume":"59","author":"Rudolph","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0575","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/pr.117.014035","article-title":"The hyperpolarization-activated cyclic nucleotide-gated channels: from biophysics to pharmacology of a unique family of ion channels","volume":"69","author":"Sartiani","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0580","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1073\/pnas.88.8.3314","article-title":"Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte\/macrophage colony-stimulating factor, but not from interleukin 4","volume":"88","author":"Satoh","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0585","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0021-9258(18)45913-3","article-title":"Inhibition of interleukin 3 and granulocyte-macrophage colony-stimulating factor stimulated increase of active ras.Gtp by herbimycin A, a specific inhibitor of tyrosine kinases","volume":"267","author":"Satoh","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0590","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0092-8674(87)90534-4","article-title":"Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene","volume":"49","author":"Seizinger","year":"1987","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0595","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.1004829107","article-title":"Neurofibromin regulates corticostriatal inhibitory networks during working memory performance","volume":"107","author":"Shilyansky","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0600","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng0397-281","article-title":"A mouse model for the learning and memory deficits associated with neurofibromatosis type I","volume":"15","author":"Silva","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0605","series-title":"A Treatise on the Pathology, Diagnosis, Treatment of Neuroma","author":"Smith","year":"1849"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0610","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/nn0109-8","article-title":"Hyperactive interneurons impair learning in a neurofibromatosis model","volume":"12","author":"Staley","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0615","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13229-018-0190-z","article-title":"Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)","volume":"9","author":"Stivaros","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0620","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.7811320","article-title":"Activation of Raf as a result of recruitment to the plasma membrane","volume":"264","author":"Stokoe","year":"1994","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0625","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0960-9822(00)00359-6","article-title":"Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42\/Rac and Pak","volume":"10","author":"Sun","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0630","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1073\/pnas.95.9.5139","article-title":"A role for Pak protein kinases in Schwann cell transformation","volume":"95","author":"Tang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0635","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0640","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein-stimulated adenylyl cyclase activity","volume":"5","author":"Tong","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0645","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1126\/science.2821624","article-title":"A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants","volume":"238","author":"Trahey","year":"1987","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0650","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-2187-9-7","article-title":"The role of p21-activated kinases in hepatocellular carcinoma metastasis","volume":"9","author":"Tse","year":"2014","journal-title":"J. Mol. Signal."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0655","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1474-4422(13)70227-8","article-title":"Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial","volume":"12","author":"Van Der Vaart","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0660","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/npp.2016.237","article-title":"Arbaclofen in children and adolescents with autism spectrum disorder: a randomized, controlled, phase 2 trial","volume":"42","author":"Veenstra-Vanderweele","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0665","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/dmcn.12038","article-title":"Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1","volume":"55","author":"Walsh","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0670","doi-asserted-by":"crossref","first-page":"20093","DOI":"10.1074\/jbc.M112.426023","article-title":"p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0675","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0680","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.celrep.2014.07.054","article-title":"Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1","volume":"8","author":"Wolman","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0685","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0092-8674(92)90076-O","article-title":"Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK","volume":"68","author":"Wood","year":"1992","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0690","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12885-016-2199-z","article-title":"Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression","volume":"16","author":"Woodfield","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0695","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.cub.2016.09.010","article-title":"NF1 is a direct G protein effector essential for opioid signaling to Ras in the striatum","volume":"26","author":"Xie","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.pbr.2018.09.014_bb0700","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0705","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuron.2010.09.013","article-title":"Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins","volume":"68","author":"Ye","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2018.09.014_bb0710","doi-asserted-by":"crossref","first-page":"26958","DOI":"10.1074\/jbc.M209413200","article-title":"Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras","volume":"278","author":"Yunoue","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Progress in Brain Research","Genetic Models and Molecular Pathways Underlying Autism Spectrum Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612318301201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612318301201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T17:46:52Z","timestamp":1662313612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612318301201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780444641946"],"references-count":141,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2018.09.014","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}